Context Therapeutics Inc. Business Finance Contracts & Agreements
14 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (4)
- Registration Rights Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (1)
- Warrant Agreements (3)
- Form of Stock (Filed With SEC on August 7, 2024)
- Form of Stock Option Agreement (Inducement Grant) of Context Therapeutics Inc (Filed With SEC on August 7, 2024)
- ASSET PURCHASE AGREEMENT (Filed With SEC on July 10, 2024)
- Registration Rights Agreement (Filed With SEC on May 2, 2024)
- Securities Purchase Agreement, dated May 1, 2024, by and between the Company and the Purchasers named therein (Filed With SEC on May 2, 2024)
- PRE-FUNDED COMMON STOCK PURCHASE WARRANT CONTEXT THERAPEUTICS INC. (Filed With SEC on May 2, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on May 11, 2022)
- Registration Rights Agreement, dated December 1, 2021, by and between Context Therapeutics Inc. and the investors named therein (Filed With SEC on December 2, 2021)
- Securities Purchase Agreement, dated December 1, 2021, by and between Context Therapeutics Inc. and the purchasers named therein (Filed With SEC on December 2, 2021)
- Form of Common Stock Purchase Warrant (Filed With SEC on December 2, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 2, 2021)
- Asset Purchase Agreement, dated as of December 15, 2017, between Context Biopharma Inc. and Arno Therapeutics, Inc (Filed With SEC on May 27, 2021)
- Investors Rights Agreement, dated December 22, 2020, among Context Therapeutics LLC and certain investors (Filed With SEC on May 27, 2021)
- Form of Stock Certificate of Common Stock (Filed With SEC on May 27, 2021)
